TWO SIGMA INVESTMENTS, LP

Position in LEGN — Legend Biotech Corp

CIK 1179392 NEW YORK, NY

Position in LEGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,733,518

-$29,463,745 QoQ

Shares Held

163,903

-91.3% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#59

of 218 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. LEGN ranks #119 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,733,518	163,903	-91.3%	Shares	Sole	2026-08-14
2026-03-31	$34,197,263	1,890,396	+259.3%	Shares	Sole	2026-05-15
2025-12-31	$11,436,761	526,070	+46.2%	Shares	Sole	2026-02-17
2025-09-30	$11,737,480	359,935	+33.5%	Shares	Sole	2025-11-14
2025-06-30	$9,571,688	269,701	-66.4%	Shares	Sole	2025-08-14
2025-03-31	$27,204,429	801,781	+24.8%	Shares	Sole	2025-05-15
2024-12-31	$20,905,388	642,452	+961.9%	Shares	Sole	2025-02-14
2024-09-30	$2,948,165	60,500	-69.3%	Shares	Sole	2024-11-14
2023-09-30	$13,247,200	197,219	+69.7%	Shares	Sole	2023-11-14
2023-06-30	$8,022,873	116,223	-36.8%	Shares	Sole	2023-08-14
2022-03-31	$6,681,545	183,862	+371.8%	Shares	Sole	2022-05-16
2021-12-31	$1,816,484	38,972	-72.5%	Shares	Sole	2022-02-14
2021-06-30	$5,816,333	141,689	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.